IPE

Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024

Retrieved on: 
Wednesday, January 10, 2024
ROW, High Court of Justice, Professional corporation, Cantor Fitzgerald, Appendix, IPE, Share repurchase, Investment, Conference, Marketing, Row, Growth, Management

-- Amarin to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 --

Key Points: 
  • Cash Position: Amarin ended 2023 with approximately $321 million in cash and investments, with positive cash flow of approximately $10 million for the full year.
  • “In 2023, our team focused and delivered on our priorities that advanced our strategy,” said Patrick Holt, President & CEO of Amarin.
  • Amarin delivered approximately 65% growth in the fourth quarter versus the third quarter 2023.
  • Amarin anticipates that these steps could be completed by the end of the second quarter of 2024, with share repurchases commencing shortly thereafter.

Align Technology Completes Acquisition of Cubicure, a Pioneer of Direct 3D Printing Solutions for Polymer Additive Manufacturing

Retrieved on: 
Wednesday, January 3, 2024
Health Technology, Health, Dental, Medical Devices, IPE, Orthodontics, Acquisition, Align Technology, 3D, 3D printing

The acquisition of Cubicure will support and scale Align’s strategic innovation roadmap and strengthen the Align Digital Platform™.

Key Points: 
  • The acquisition of Cubicure will support and scale Align’s strategic innovation roadmap and strengthen the Align Digital Platform™.
  • This high precision 3D printing process facilitates the unprecedented additive manufacturing of resilient components with an astonishing first of its kind material quality performance.
  • Commenting on today’s announcement, Joe Hogan, Align Technology president and CEO said, “The acquisition of Cubicure brings a talented team and unique cutting-edge technology into Align and will enable us to scale our 3D printing operations to eventually direct print millions of custom appliances per day.
  • Direct 3D printing enables Align to create 3D printed solutions without the added step of first creating a mold, making 3D printing more sustainable and efficient.

Align Technology Receives US FDA 510(k) Clearance for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally

Retrieved on: 
Monday, December 18, 2023
Health, FDA, Medical Devices, Technology, Software, Dental, Clinical Trials, Align Technology, Research, Food, Maxilla, Anatomy, Orthodontics, Multimedia, Patient, Emergency, Movement, IPE, IDE, Trial of the century, Dentition, Splint (medicine), 3D, Parent, Mouth, Investigational New Drug, Align, Medical device, Dentistry, Pharmaceutical industry

The FDA 510(k) clearance is for broad patient applicability, including growing children, teens, and adults (with surgery or other techniques).

Key Points: 
  • The FDA 510(k) clearance is for broad patient applicability, including growing children, teens, and adults (with surgery or other techniques).
  • Invisalign Palatal Expanders are intended for use in rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla (upper jaw) with primary, mixed, or permanent dentition during treatment of patients.
  • **Based on data from a multi-site US IDE (Investigational Device Exemption) clinical study (n=29 subjects, ages 7-10 years) of expansion treatment with Invisalign® Palatal Expanders.
  • Data on file at Align Technology, Inc. as of October 30, 2023
    ***Data on File at Align Technology, Inc. as of June 2021.

Health Canada Issues Updated Medical Device License to Align Technology For the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion

Retrieved on: 
Wednesday, December 13, 2023
Health, Dental, Medical Devices, Align Technology, Health Canada, Food, Maxilla, Oral hygiene, Anatomy, Orthodontics, Multimedia, Patient, Movement, IPE, Child, IDE, Trial of the century, Dentition, Pain, 3D, Parent, Mouth, Investigational New Drug, Dentistry, Align

Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Health Canada issued an updated medical device license to Align for its Invisalign® Palatal Expander System*.

Key Points: 
  • Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Health Canada issued an updated medical device license to Align for its Invisalign® Palatal Expander System*.
  • The Invisalign Palatal Expander System is available on a limited basis in Canada.
  • (Photo: Business Wire)
    Previously introduced at the Align Technology Investor Day in September 2023, the Invisalign Palatal Expander System is a modern and innovative direct 3D printed device based on proprietary and patented technology.
  • Data on file at Align Technology, Inc. as of October 30, 2023
    ***Data on File at Align Technology, as of June 2021.

IPEC Releases Updated Version of the Core Competencies for Interprofessional Collaborative Practice

Retrieved on: 
Monday, November 20, 2023
Practice Management, Nursing, Health, Other Education, Continuing, Education, Training, Other Health, Research, Policy, Organization, Learning, Student, Multimedia, IPEC, Data analysis, Appendix, IPE, Central Waqf Council, School, MD, Population health, AAMC, Management

The Interprofessional Education Collaborative (IPEC) is pleased to announce the release of the IPEC Core Competencies for Interprofessional Collaborative Practice: Version 3 .

Key Points: 
  • The Interprofessional Education Collaborative (IPEC) is pleased to announce the release of the IPEC Core Competencies for Interprofessional Collaborative Practice: Version 3 .
  • First published in 2011 and updated in 2016, the IPEC competencies have become an indispensable resource to advance interprofessional education for collaborative practice (IPECP).
  • To support users, the IPEC Core Competencies for Interprofessional Collaborative Practice: Version 3 contains a compendium of materials:
    A brief history of IPEC (Appendix A) detailing collective milestones from 2009 to the present day.
  • Click here to review Version 3 of the IPEC Core Competencies for Interprofessional Collaborative Practice .

Radiology Partners Deploys Clinical AI Across More Than 20 Million Annual Patient Exams

Retrieved on: 
Monday, November 13, 2023
Software, Radiology, Hardware, Oncology, Data Management, Medical Devices, Technology, Hospitals, Artificial Intelligence, Health Technology, Practice Management, Health, Cloud, ICH, Natural language processing, Pulmonary embolism, Organization, RP, IPE, ROI, Teleradiology, Chairperson, Breast cancer, Triage, Patient, Artificial intelligence, NLP, Partner, Workflow, Diagnosis, Partnership, Bone fracture, Hospital, AI, Storage area network, Intracranial hemorrhage, Medical device, Aidoc

By deploying AI across more than 20 million annual exams already this calendar year, RP’s investment in advancing and expanding AI demonstrates its commitment to elevating patient care, enhancing outcomes and improving ROI for clients committed to advancing healthcare.

Key Points: 
  • By deploying AI across more than 20 million annual exams already this calendar year, RP’s investment in advancing and expanding AI demonstrates its commitment to elevating patient care, enhancing outcomes and improving ROI for clients committed to advancing healthcare.
  • Dr. Nina Kottler, RP’s Associate Chief Medical Officer for Clinical AI, emphasized the transformative impact of AI: “Radiologists have long been considered the doctor's doctor.
  • Currently, more than 2,600 of RP’s 3,600 radiologists are using at least one AI tool within their daily workflow.
  • Through this cutting-edge clinical innovation, RP radiologists have enhanced patient care and improved the quality of their output.

LONGi Achieves Nearly 40% Reduction in Operational Emissions in Climate Action White Paper Released at COP28

Retrieved on: 
Thursday, December 7, 2023
Sustainable development, Disclosure, Carbon, Research, Climate change, COP28, Commitment, Science, International Sustainability Standards Board, ISSB, Institute of Public Affairs, Science Based Targets initiative, IPE, Annual report, Task force, CATI, Conference, Value chain, LONGi Green Energy Technology, Electricity, White paper, Renewable energy, LONGi

DUBAI, UAE, Dec. 7, 2023 /PRNewswire/ -- LONGi Green Energy Technology Co., Ltd. (LONGi), a global leader in solar technology, today released its 2023 Climate Action White Paper, a comprehensive report outlining the company's commitment, achievements, and future strategies to promote sustainable development through clean energy. The white paper highlights monumental strides toward clean energy development, including where LONGi slashed operational emissions per revenue unit by nearly 40 percent in 2022. Additionally, 47 percent of LONGi's total electricity consumption is now sourced from sustainable alternatives, eliminating approximately 2.5 million tons of carbon dioxide emissions.

Key Points: 
  • The white paper highlights monumental strides toward clean energy development, including where LONGi slashed operational emissions per revenue unit by nearly 40 percent in 2022.
  • Additionally, 47 percent of LONGi's total electricity consumption is now sourced from sustainable alternatives, eliminating approximately 2.5 million tons of carbon dioxide emissions.
  • The accompanying white paper delves into four key chapters: Task Force on Climate-related Financial Disclosures Accelerating Operational Emissions Reduction, Enhancing a Low-carbon Value Chain, and Advancing Toward a Zero-carbon Future.
  • "The annual publishing of our white paper is meant to show our firm ambition, pragmatic action, and progress in climate action to all of society.

LONGi Achieves Nearly 40% Reduction in Operational Emissions in Climate Action White Paper Released at COP28

Retrieved on: 
Thursday, December 7, 2023
Sustainable development, Disclosure, Carbon, Research, Climate change, COP28, Commitment, Science, International Sustainability Standards Board, ISSB, Institute of Public Affairs, Science Based Targets initiative, IPE, Annual report, Task force, CATI, Conference, Value chain, LONGi Green Energy Technology, Electricity, White paper, Renewable energy, LONGi

DUBAI, UAE, Dec. 7, 2023 /PRNewswire/ -- LONGi Green Energy Technology Co., Ltd. (LONGi), a global leader in solar technology, today released its 2023 Climate Action White Paper, a comprehensive report outlining the company's commitment, achievements, and future strategies to promote sustainable development through clean energy. The white paper highlights monumental strides toward clean energy development, including where LONGi slashed operational emissions per revenue unit by nearly 40 percent in 2022. Additionally, 47 percent of LONGi's total electricity consumption is now sourced from sustainable alternatives, eliminating approximately 2.5 million tons of carbon dioxide emissions.

Key Points: 
  • The white paper highlights monumental strides toward clean energy development, including where LONGi slashed operational emissions per revenue unit by nearly 40 percent in 2022.
  • Additionally, 47 percent of LONGi's total electricity consumption is now sourced from sustainable alternatives, eliminating approximately 2.5 million tons of carbon dioxide emissions.
  • The accompanying white paper delves into four key chapters: Task Force on Climate-related Financial Disclosures Accelerating Operational Emissions Reduction, Enhancing a Low-carbon Value Chain, and Advancing Toward a Zero-carbon Future.
  • "The annual publishing of our white paper is meant to show our firm ambition, pragmatic action, and progress in climate action to all of society.

Manulife Investment Management Announces Close on up to $224.5 Million in Commitments to Forest Climate Fund

Retrieved on: 
Friday, November 10, 2023
Carbon, Regulation D, FCF, Agriculture, Research, National Integration Council, Climate change, European Commission, Forest management, Investment, The Carbon Principles, Climate, Advertising, IPE, Documentation, Enterprise Architecture Assessment Framework, Rule, FINRA, SFDR, AUM, Forest Stewardship Council, Natural capital, Renewable energy, Financial adviser, Manulife

BOSTON, Nov. 10, 2023 /PRNewswire/ - Manulife Investment Management, the world's largest manager of natural capital with nearly $15 billion in assets under management in timberland and agriculture combined, today announced the initial close of Manulife Forest Climate Fund LP1,2 (FCF or the fund).

Key Points: 
  • BOSTON, Nov. 10, 2023 /PRNewswire/ - Manulife Investment Management, the world's largest manager of natural capital with nearly $15 billion in assets under management in timberland and agriculture combined, today announced the initial close of Manulife Forest Climate Fund LP1,2 (FCF or the fund).
  • Along with its affiliated offshore vehicles, the fund has secured commitments totaling up to $224.5 million towards its $500 million targeted offering.
  • "The Manulife Forest Climate Fund expands on our decades of sustainable timberland management experience and is one of the natural climate solutions we have developed to sequester carbon more intensively and drive broader impact," added Eric Cooperstrom, managing director, impact investing and natural climate solutions, Manulife Investment Management.
  • The fund will be distributed in the United States by John Hancock Investment Management Distributors LLC, member FINRA, a Manulife IM affiliate.

Amarin Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 1, 2023
Research, SMC, Medicare, Prescription, Risk, Forecasting, CVRR, Telephone, Health technology assessment, GAAP, HTA, Commercial, Marketing, Healthcare Improvement Scotland, Professional corporation, Investment, Patient, Hypertriglyceridemia, National Medical Products Administration, Conference, Organization, IPE, Medicaid, NMPA, File, Socialist Alternative (England, Wales & Scotland), ASEAN, Rare-earth element, Management, Pharmaceutical industry, Health insurance, Video game, Cryptocurrency, Bank, Amarin

-- Company to Host Conference Call Today at 8:00 a.m. ET --

Key Points: 
  • ET --
    DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced financial results for the quarter ended September 30, 2023 and provided an update on company operations.
  • “As we focus on demonstrating results that will drive shareholder value, there are reasons to be optimistic about the future of Amarin,” said Patrick Holt, President & CEO of Amarin.
  • U.S. product net revenue was $62.4 million in the third quarter of 2023, a decline of $2.2 million versus the second quarter of 2023, a decrease of 3% sequentially.
  • The company has provided these non-GAAP financial measures in addition to GAAP financial results because it believes that these non-GAAP adjusted financial measures provide investors with a better understanding of the company’s historical results from its core business operations.